|1.||Kang, Duk-Hee: 1 article (07/2014)|
|2.||Choi, You-Jin: 1 article (07/2014)|
|3.||Lee, Jeewoo: 1 article (07/2014)|
|4.||Lee, Byung-Hoon: 1 article (07/2014)|
|5.||Kim, Kyong-Cheol: 1 article (07/2014)|
|6.||Lee, Seung Mi: 1 article (07/2014)|
|7.||Lee, Kang-Yo: 1 article (07/2014)|
|8.||Yoon, Yujin: 1 article (07/2014)|
|9.||Hien, Tran Thi: 1 article (07/2014)|
|10.||Lee, Moo-Yeol: 1 article (07/2014)|
09/01/1987 - "The present study was done to evaluate the utility of allantoxanamide for investigating problems concerning hyperuricemia using rats. "
07/01/2014 - "Treatment of rats with the uricase inhibitor allantoxanamide induced mild hyperuricemia and increased mean arterial pressure by 25%. "
09/01/1987 - "Thus, we concluded that allantoxanamide might be a useful reagent for investigating the causes of hyperuricemia with renal failure, but was not a practical agent like oxonate in order to evaluate the response to uricosuric agents."
09/01/1987 - "Such a severe and long-lasting hyperuricemia caused by allantoxanamide was due to decreased renal function of uric acid excretion according to its nephrotoxicity in addition to the inhibition of urate oxidase like that by oxonate. "
|2.||Renal Insufficiency (Renal Failure)
|1.||Urate Oxidase (Uricase)
|3.||Uric Acid (Urate)